These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38605438)

  • 1. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.
    Kotton CN; Kamar N; Wojciechowski D; Eder M; Hopfer H; Randhawa P; Sester M; Comoli P; Tedesco Silva H; Knoll G; Brennan DC; Trofe-Clark J; Pape L; Axelrod D; Kiberd B; Wong G; Hirsch HH;
    Transplantation; 2024 Sep; 108(9):1834-1866. PubMed ID: 38605438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for BK virus infection in kidney transplant recipients.
    Wajih Z; Karpe KM; Walters GD
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD013344. PubMed ID: 39382091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
    Kaur A; Wilhelm M; Wilk S; Hirsch HH
    Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
    Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
    BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.
    Gabardi S; Pavlakis M; Tan C; Francis J; Cardarelli F; Asch W; Bodziak K; Chobanian M; Gilligan H; Gohh R; Kung SC; Inker L; Martin S; Rodig N; Rossi A; Chandraker A
    Transpl Infect Dis; 2018 Dec; 20(6):e12985. PubMed ID: 30175491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 17. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.